Development of therapeutic gaba-producing bacteria

Ended Project Grant Awarded Last action

Award ID
R44DK120181
Recipient
Awarding agency
Obligated
$2,966,941

Award facts

Assistance listing
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
Completion date
Originally
Funding
  • $2,299,339.00 Federal
  • $667,602.00 Non-federal
Place of performance
Cambridge, MA 02139, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $667,602 $0
Amendment Development of therapeutic gaba-producing bacteria - the goal of this project is to develop therapeutics to treat visceral pain (a symptom of irritable bowel… $667,602 $667,602
Amendment $664,418 $0
Amendment -$664,418 $0
Amendment $664,418 $0
Amendment $0 $0
Amendment $299,717 $0
Amendment -$299,717 $0
Original award $299,717 $0
Show all 12

Quick answers

Who received award R44DK120181?

R44DK120181 was awarded to Holobiome, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on June 1, 2019.

How much is award R44DK120181 worth?

$2,966,941 has been obligated on R44DK120181: $2,299,339 in federal funding and $667,602 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award